Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level

Kern, Marialice; Wells, James A.; Stephens, Jacqueline M.; Elton, Colin; Friedman, Jacqueline; Tapscott, Edward B.; Pekala, Phillip H.; Dohm, G. Lynis

doi:10.1042/bj2700397

Cited by 236 publications

(165 citation statements)

References 22 publications

Supporting

Mentioning

142

Contrasting

Unclassified

Order By: Relevance

“…24,31 In the present investigation, we found that chronic antagonism of Ang II receptors caused small (15% to 22%) but significant increases in GLUT-4 protein expression in both oxidative (soleus) and substantially glycolytic (plantaris) skeletal muscle and in the highly oxidative myocardium (Figure 7). At least in the soleus muscle, this increase in GLUT-4 protein could have contributed to enhancement of insulin action on glucose transport after chronic irbesartan treatment.…”

Section: Discussionmentioning

confidence: 76%

Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats

et al. 2001

View full text Add to dashboard Cite

Abstract-Effects of oral administration of the angiotensin II receptor antagonist (selective AT 1 -subtype) irbesartan on glucose tolerance and insulin action on skeletal-muscle glucose transport were assessed in the insulin-resistant obese Zucker rat. In the acute study, obese rats received either vehicle (water) or irbesartan 1 hour before the experiment. Although irbesartan had no effect on glucose transport (2-deoxyglucose uptake) in the epitrochlearis muscle, which consists mainly of type IIb fibers, acute angiotensin II receptor antagonism led to a dose-dependent increase in insulin action in the predominantly type I soleus muscle. Irbesartan at 25 and 50 mg/kg induced significant increases (41% and 50%, respectively; PϽ0.05) in insulin-mediated glucose transport. Moreover, these acute irbesartan-induced improvements in soleus-muscle glucose transport were associated with enhancements in whole-body insulin sensitivity (rϭϪ0.732; PϽ0.05), as assessed during an oral glucose tolerance test. After chronic administration of irbesartan (21 days at 50 mg · kg), glucose tolerance was enhanced further, and insulin-mediated glucose transport was significantly elevated in both epitrochlearis (32%) and soleus (73%) muscle. Chronic angiotensin II receptor antagonism was associated with significant increases in glucose transporter-4 (GLUT-4) protein expression in soleus (22%) and plantaris (20%) muscle and myocardium (15%). Chronic irbesartan-induced increases in whole-body insulin sensitivity were associated with increased insulin-mediated glucose transport in both epitrochlearis (rϭϪ0.677; PϽ0.05) and soleus (rϭϪ0.892; PϽ0.05) muscle. In summary, angiotensin II receptor (AT 1 -subtype) antagonism, either acutely or chronically, improves glucose tolerance, at least in part because of an enhancement in skeletal-muscle glucose transport, and the effect of chronic angiotensin II receptor antagonism on type I skeletal-muscle glucose uptake is associated with an increase in GLUT-4 protein expression. Key Words: irbesartan Ⅲ glucose Ⅲ muscle, skeletal Ⅲ transport, glucose Ⅲ rats, Zucker Ⅲ receptors, angiotensin I ndividuals with essential hypertension frequently display a clustering of additional atherogenic risk factors, including insulin resistance of skeletal-muscle glucose uptake, hyperinsulinemia, dyslipidemia, and central adiposity, in a condition described as "insulin resistance syndrome." 1 Angiotensin (Ang) II is a potent vasoconstrictor and can contribute to the pathogenesis of hypertension. 2 Reductions in formation of Ang II, as results from treatment with ACE inhibitors or inhibition of the cellular actions of Ang II by the use of specific Ang II (AT 1 -subtype) antagonists, are effective interventions for lowering blood pressure. [3][4][5] Although both animal model studies 6 -12 and clinical investigations 6,[13][14][15][16][17][18] have demonstrated that ACE inhibitor treatment can ameliorate peripheral insulin resistance, the role of a specific reduction in Ang II action on whole-body and skeletal-muscle ins...

show abstract

Section: Discussionmentioning

confidence: 76%

Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats

et al. 2001

View full text Add to dashboard Cite

show abstract

“…Bovine and fetal bovine sera were purchased from HyClone, Logan, Utah. All radiolabeled compounds were obtained from New England Nuclear, Boston, Mass., or ICN Biomedicals Inc., Irvine, Calif. GLUT1 and GLUT4 antibodies were prepared and characterized as previously described (22). The 3T3-L1 cells used in these experiments were obtained from Howard Green, Harvard University, Boston, Mass.…”

Section: Methodsmentioning

confidence: 99%

Ectopic Expression of Hel-N1, an RNA-Binding Protein, Increases Glucose Transporter (GLUT1) Expression in 3T3-L1 Adipocytes

Jain

Andrews

McGowan

et al. 1997

Molecular and Cellular Biology

Self Cite

187

174

View full text Add to dashboard Cite

3T3-L1 preadipocytes ectopically expressing the mammalian RNA-binding protein Hel-N1 expressed up to 10-fold more glucose transporter (GLUT1) protein and exhibited elevated rates of basal glucose uptake. Hel-N1 is a member of the ELAV-like family of proteins associated with the induction and maintenance of differentiation in various species. ELAV proteins are known to bind in vitro to short stretches of uridylates in the 3 untranslated regions (3 UTRs) of unstable mRNAs encoding growth-regulatory proteins involved in transcription and signal transduction. GLUT1 mRNA also contains a large 3 UTR with a U-rich region that binds specifically to Hel-N1 in vitro. Analysis of the altered GLUT1 expression at the translational and posttranscriptional levels suggested a mechanism involving both mRNA stabilization and accelerated formation of translation initiation complexes. These findings are consistent with the hypothesis that the Hel-N1 family of proteins modulate gene expression at the level of mRNA in the cytoplasm.Interaction of RNA-binding proteins with cis elements in mRNAs is believed to be involved in regulation of their stability and translational efficiency (reviewed in reference 32). The regulated stability of transferrin, granulocyte-macrophage colony-stimulating factor, and histone mRNAs has been shown, at least in part, to be controlled by the binding of specific proteins to consensus sequences in the 3Ј untranslated region (3ЈUTR) of these messages (3, 37, 41). Studies of tobacco mosaic virus, the Drosophila melanogaster developmental gene hunchback, human cytokine, and 15-lipoxygenase mRNAs have demonstrated that the 3ЈUTR also contains information capable of regulating translational efficiency which may be mediated by RNA-binding proteins (13,25,35,36). A major class of RNA-binding proteins which possess an 80-amino-acid consensus element, termed the RNA recognition motif (RRM) (39), which forms the core of a functional RNAbinding domain has been identified.Hel-N1 (human embryonic lethal abnormal vision [ELAV]-like neuronal protein 1), a mammalian homolog of Drosophila ELAV, is an mRNA-binding protein of the RRM family (15,16,27). Recent studies on Hel-N1, and the alternative form, Hel-N2 (lacking a 13-amino-acid segment between RRM2 and RRM3), in human medulloblastoma cells and embryonic carcinoma P19 cells have indicated that it plays a role in mRNA metabolism (15). These proteins are bound to poly(A) ϩ mRNA in granular RNP structures, and their expression is upregulated during neuronal cell differentiation of P19 cells (15). Likewise, hNT2 cells when induced to differentiate by retinoic acid exhibited a marked increase in the expression of human ELAV-like proteins which colocalized with mRNPs associated with polysomes (1). Hence, data from both of these studies support an important role for mammalian ELAV-like proteins in the processes of cell growth and differentiation.Interestingly, members of the ELAV family have been shown to bind the AU-rich regions of the 3ЈUTRs in cytokine and proto-oncogene m...

show abstract

“…Translocation of intracellular vesicles containing the insulinresponsive glucose transporter Glut4 to the cell surface is one of the most important effects of insulin in adipose and skeletal muscle tissues (1)(2)(3)(4). In the absence of insulin, approximately 95% of cellular Glut4 is sequestered in an intracellular compartment.…”

mentioning

confidence: 99%

The Amino Terminus of Insulin-responsive Aminopeptidase Causes Glut4 Translocation in 3T3-L1 Adipocytes

Waters¹,

D'Auria²,

Martin³

et al. 1997

Journal of Biological Chemistry

113

View full text Add to dashboard Cite

The insulin-responsive aminopeptidase (IRAP) is a constituent of the vesicles that contain the insulin-regulated glucose transporter (Glut4). Like Glut4, IRAP translocates to the cell surface in response to insulin. Microinjection into 3T3-L1 adipocytes of a glutathione S-transferase (GST) fusion protein containing the cytosolic portion of IRAP (GST-IRAP-(1-109)), resulted in translocation of Glut4 to the cell surface. Immunostaining of 3T3-L1 adipocytes for Glut4 showed that the percentage of cells with substantial cell surface Glut4 was 10% in unstimulated cells, 8% following injection of GST, and 27% following injection of GST-IRAP-(1-109). Increased cell surface Glut4 occurred within 5-10 min following injection and was maintained for at least 4 h. A fusion protein containing only 28 amino acids from IRAP (GST-IRAP-(55-82)) was as effective in increasing cell surface Glut4 as stimulation with 100 nM insulin (44% versus 43%, respectively). In contrast to insulinstimulated Glut4 translocation, the redistribution of Glut4 following injection of GST-IRAP-(55-82) was not blocked by wortmannin or co-injection with a SH2 domain from the regulatory subunit of phosphatidylinositol 3-kinase. These data suggest that the amino terminus of IRAP interacts with a retention/sorting protein that also regulates the distribution of Glut4 in insulin-responsive cells.

show abstract

Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level

Cited by 236 publications

References 22 publications

Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats

Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats

Ectopic Expression of Hel-N1, an RNA-Binding Protein, Increases Glucose Transporter (GLUT1) Expression in 3T3-L1 Adipocytes

The Amino Terminus of Insulin-responsive Aminopeptidase Causes Glut4 Translocation in 3T3-L1 Adipocytes

Contact Info

Product

Resources

About